• Western blot analysis of A-549, using SOX1 Rabbit monoclonal antibody (STJ11103595) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.

Anti-SOX1 antibody (1-100) [S5MR] (STJ11103595)

SKU:
STJ11103595

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: S5MR
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SOX1
Gene ID: 6656
Uniprot ID: SOX1_HUMAN
Immunogen Region: 1-100
Specificity: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human SOX1 (O00570).
Immunogen Sequence: MYSMMMETDLHSPGGAQAPT NLSGPAGAGGGGGGGGGGGG GGGAKANQDRVKRPMNAFMV WSRGQRRKMAQENPKMHNSE ISKRLGAEWKVMSEAEKRPF
Tissue Specificity Mainly expressed in the developing central nervous system.
Function Transcriptional activator. May function as a switch in neuronal development. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation.
Protein Name Transcription Factor Sox-1
Database Links Reactome: R-HSA-9823739
Reactome: R-HSA-9832991
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Transcription Factor Sox-1 antibody
Anti-SOX1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance